Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population.

Robert J Pignolo¹, John J Connell², Will Briggs³, Catherine J Kelly³, Chris Tromans³, Naima Sultana³, J Michael Brady³

¹Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.

²Naitive Technologies Ltd, London, EC1N 2SW, UK. john.connell@naitive.com.

³Naitive Technologies Ltd, London, EC1N 2SW, UK.

PubMed PMC DOI PDF

Abstract

UNLABELLED: Identifying patients at risk of low bone mineral density (BMD) from X-rays presents an attractive approach to increase case finding. This paper showed the diagnostic accuracy, reproducibility, and robustness of a new technology: OsteoSight™. OsteoSight could increase diagnosis and preventive treatment rates for patients with low BMD. PURPOSE: This study aimed to evaluate the diagnosti…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.